
    
      The drug being tested in this study is called Glatiramer acetate is being tested to treat
      people who have Multiple sclerosis. This study will look at the safety and efficacy of
      Glatiramer acetate in patients with multiple sclerosis in the routine clinical setting.

      The study will enroll approximately 1000 patients.

      â€¢ Glatiramer acetate subcutaneous injection syringe

      This multi-center trial will be conducted in Japan.
    
  